Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Upstream Bio (UPB) Research & Development: 2023-2024

Historic Research & Development for Upstream Bio (UPB) over the last 2 years, with Dec 2024 value amounting to $63.0 million.

  • Upstream Bio's Research & Development rose 113.67% to $33.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $118.4 million, marking a year-over-year increase of 124.49%. This contributed to the annual value of $63.0 million for FY2024, which is 98.01% up from last year.
  • According to the latest figures from FY2024, Upstream Bio's Research & Development is $63.0 million, which was up 98.01% from $31.8 million recorded in FY2023.
  • In the past 5 years, Upstream Bio's Research & Development ranged from a high of $63.0 million in FY2024 and a low of $31.8 million during FY2023.
  • Its 2-year average for Research & Development is $47.4 million, with a median of $47.4 million in 2023.
  • Data for Upstream Bio's Research & Development shows a peak YoY soared of 98.01% (in 2024) over the last 5 years.
  • Upstream Bio's Research & Development (Yearly) stood at $31.8 million in 2023, then skyrocketed by 98.01% to $63.0 million in 2024.